Robin M Warren, Paul D van Helden. Show Affiliations »
Abstract
Entities: Disease
Mesh: See more » Antitubercular Agents/therapeutic useHIV SeronegativityHIV SeropositivityHIV-1/immunologyHumansMiningOccupational ExposureRecurrenceRisk FactorsSouth Africa/epidemiologyTuberculosis, Pulmonary/drug therapyTuberculosis, Pulmonary/epidemiologyTuberculosis, Pulmonary/etiology
Substances: See more » Antitubercular Agents
Year: 2002 PMID: 12047995 DOI: 10.1016/S0140-6736(02)08496-9
Source DB: PubMed Journal: Lancet ISSN: 0140-6736 Impact factor: 79.321